StemPar Sciences Company
StemPar is developing a pipeline of powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their
Employee Number:
1-10
Funding Status:
Private Equity
Headquarters:
Mill Valley, California, United States
Technology:
Others
Estimated Revenue:
$1M to $10M
Founded Date:
2009
Industry:
PharmTech